Can HRT Affect Weight Loss on Semaglutide or Tirzepatide? What Research Shows

Can hormone therapy improve GLP-1 weight-loss results?

Some observational studies suggest menopausal hormone therapy is associated with greater weight loss in women taking semaglutide or tirzepatide. However, results vary, and these studies do not prove that hormone therapy causes additional weight loss. HRT is not a weight-loss treatment and should not be started solely to improve GLP-1 results.

If you’re navigating menopause while taking weight-loss medication, it makes sense to ask how the two fit together. Changes in sleep, symptoms, activity, and body composition can make this stage of life feel different from earlier weight-loss attempts.

New research is helping clarify the connection—and the questions that still need answers.

Why can weight management become harder around menopause?

Midlife weight changes have several contributors. Aging, activity levels, sleep, and changes in muscle mass can all matter. Menopause-related hormonal changes also influence where fat is stored, with more fat tending to accumulate around the abdomen.

That does not mean every plateau is caused by a hormone imbalance. It means a useful evaluation looks beyond the scale and considers your symptoms, health history, nutrition, activity, and treatment progress.

What does the research say about HRT and semaglutide?

A 2024 retrospective study compared 106 postmenopausal women taking semaglutide: 16 used menopausal hormone therapy and 90 did not. At 12 months, average total body weight loss was approximately 16% in the hormone-therapy group versus 12% in the group without it.

That is a difference of about four percentage points of starting body weight. It is not a prediction of what an individual patient will lose.

The association remained after researchers adjusted for potential confounders, but the small hormone-therapy group and observational design limit the conclusions. Participants were not randomly assigned to take HRT.

What did newer research find about tirzepatide?

In January 2026, Mayo Clinic reported a published observational study involving 120 postmenopausal women treated with tirzepatide for at least 12 months. Hormone-therapy use was associated with approximately 35% greater weight loss relative to the comparison group. That does not mean participants lost 35% of their starting weight.

Researchers cautioned that the study could not establish cause and effect. Differences in health behaviors or improvements in menopause symptoms could help explain the association.

What did the October 2026 research add?

An October 2026 Menopause Society announcement described a larger retrospective study prepared for its annual meeting. It included nearly 2,400 women taking semaglutide and nearly 1,500 taking tirzepatide, all older than 45 with a BMI above 27.

Hormone therapy was associated with greater, sustained weight loss in the semaglutide group. In the tirzepatide group, an initial advantage did not remain statistically significant at the final assessment.

The findings add to the evidence but also show why the medications should not be treated as interchangeable in this discussion. This update is based on the Society’s conference announcement, rather than an independently reviewed full report of that larger study. Randomized trials are needed to clarify whether HRT itself changes treatment response.

Should you start HRT to lose more weight?

No. These findings do not establish a reason to prescribe menopausal hormone therapy solely for weight loss.

Hormone therapy may be appropriate for bothersome menopause symptoms, depending on your medical history and individual benefits and risks. It may also help with sleep when hot flashes or night sweats are keeping you awake, which can make healthy routines easier to maintain. It has not been established as a stand-alone weight-loss treatment.

An evaluation should address both questions: Is weight-management treatment appropriate for you, and do your menopause symptoms warrant treatment?

Do you need hormone testing if your weight loss stalls?

Not automatically. A plateau alone does not establish a hormone disorder or mean you need a comprehensive hormone panel.

During typical perimenopause, hormone levels fluctuate, so symptoms, age, and menstrual history often provide more useful information than a single hormone measurement. Testing may be appropriate in selected situations or to investigate another suspected condition.

Tell your provider about hot flashes, night sweats, menstrual changes, sleep disruption, persistent fatigue, or other new symptoms. That history helps guide an evaluation rather than assuming every concern has the same cause.

Does this research apply to testosterone or hormone pellets?

These findings should not be extended to every hormone, dose, or delivery method. The research discussed here focuses on menopausal hormone therapy; it does not establish that testosterone therapy, a specific pellet regimen, or hormone treatment in men improves GLP-1 weight-loss results.

Ask your provider how the evidence relates to the particular treatment you are considering.

A personalized approach to menopause and weight management in Metairie

At Chronos Body Health & Wellness in Metairie, our physician-led team offers hormone evaluations, medical weight management, nutrition counseling, and fitness support.

If your progress has slowed or menopause symptoms are affecting daily life, a consultation can help you understand what deserves attention and which treatment options may fit your needs.

Explore women’s hormone therapy or medical weight management, or call 504-267-4549 to discuss scheduling.

1. Get a comprehensive hormone panel – This includes thyroid, sex hormones, cortisol, and other relevant markers.
   
2. Work with a qualified provider – HRT is personalized. Your plan should consider your age, medical history, and weight loss goals.
   
3. Integrate lifestyle strategies – Nutrition, exercise, and stress management remain important for overall results.
4. Track progress – Hormone optimization combined with GLP-1 therapy can accelerate weight loss and improve overall wellness.
   

Tirzepatide and semaglutide are powerful tools, but hormones often play a silent role in weight loss success. If your results aren’t matching your effort, it’s not you, it could be your hormones. By addressing hormone imbalances, you can unlock the full potential of your weight loss journey and feel more like yourself again.

Curious if HRT could help your tirzepatide or semaglutide results? Schedule a consultation with Dr. Mace Scott today and find out how balancing your hormones can accelerate your transformation.